Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
Boehringer Ingelheim
AstraZeneca
Merck

Last Updated: January 18, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Volitinib


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Volitinib?

Volitinib is an investigational drug.

There have been 34 clinical trials for Volitinib. The most recent clinical trial was a Phase 2 trial, which was initiated on August 31st 2021.

The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, and Lung Neoplasms. The leading clinical trial sponsors are AstraZeneca, Hutchison Medipharma Limited, and Parexel.

There are seventeen US patents protecting this investigational drug and two hundred and seventy-three international patents.

Recent Clinical Trials for Volitinib
TitleSponsorPhase
Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLCGuangdong Association of Clinical TrialsPhase 2
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCCAstraZenecaPhase 3
Clinical Study on Savolitinib + Osimertinib in Treatment of EGFRm+/MET+ Locally Advanced or Metastatic NSCLCHutchison Medipharma LimitedPhase 3

See all Volitinib clinical trials

Clinical Trial Summary for Volitinib

Top disease conditions for Volitinib
Top clinical trial sponsors for Volitinib

See all Volitinib clinical trials

US Patents for Volitinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Volitinib ⤷  Sign up for a Free Trial Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Sign up for a Free Trial
Volitinib ⤷  Sign up for a Free Trial Compounds and methods for inhibiting JAK Dizal (Jiangsu) Pharmaceutical Co., Ltd. (Wuxi, Jiangsu Province, CN) ⤷  Sign up for a Free Trial
Volitinib ⤷  Sign up for a Free Trial Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Sign up for a Free Trial
Volitinib ⤷  Sign up for a Free Trial Tank-binding kinase inhibitor compounds Gilead Sciences, Inc. (Foster City, CA) ⤷  Sign up for a Free Trial
Volitinib ⤷  Sign up for a Free Trial Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Sign up for a Free Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Volitinib

Drugname Country Document Number Estimated Expiration Related US Patent
Volitinib Australia AU2017261372 2036-05-05 ⤷  Sign up for a Free Trial
Volitinib Canada CA3023278 2036-05-05 ⤷  Sign up for a Free Trial
Volitinib China CN107847398 2036-05-05 ⤷  Sign up for a Free Trial
Volitinib European Patent Office EP3452003 2036-05-05 ⤷  Sign up for a Free Trial
Volitinib Hong Kong HK1249728 2036-05-05 ⤷  Sign up for a Free Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
McKesson
Boehringer Ingelheim
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.